As opposed to augmenting apoptosis, blocking sFasL signaling partially reduced HD memory B-cell apoptosis (30.5 ± 1.6% vs. 23.7 ± 1.3%, p = 0.007) whereas neutralization of sCD40L had no impact. Here, FASLG is linked to Huntington disease.